To what extent does anti-mullerian hormone contribute to a better prediction of live birth after IVF?
Catherine Rongieres, Carolina Colella, Philippe Lehert
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS | SPRINGER/PLENUM PUBLISHERS | Published : 2015
OBJECTIVE: We assessed the predictive value added by Anti-Mullerian Hormone (AMH) to currently validated live birth (LB) prediction models. METHODS: Based on recent data from our center, we compared the external validity of the Templeton Model (TM) and its recent improvement (TMA) to select our model of reference. The added predictive value of AMH was assessed in testing the likelihood ratio significance and the Net Reclassification Index (NRI). The surrogate utility of AMH was tested by conducting an exploratory stepwise logistic regression. RESULTS: Based on 715 cycles, the original TM had poor performances (auROC C = 0.61 [0.58, 0.66], improving by fitting TM to our data (C = 0.71[0.66, 0..View full abstract